Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Earnings

ScanSource Posts Strong Quarterly Finish Amid Annual Revenue Decline

Dieter Jaworski by Dieter Jaworski
September 4, 2025
in Earnings, Tech & Software, Trading & Momentum
0
ScanSource Stock
0
SHARES
204
VIEWS
Share on FacebookShare on Twitter

Technology distributor ScanSource concluded its fiscal year 2025 with a surprisingly robust final quarter. Although annual revenue experienced a contraction, profitability saw significant improvement, driven by a strategic company-wide shift toward recurring revenue streams.

Annual Performance: A Contrast in Results

A review of the full fiscal year presents a nuanced financial picture. Total annual revenue declined by 6.7 percent, settling at $3.04 billion. Despite this top-line decrease, the company achieved a notable improvement in its bottom line. Gross profit for the year advanced by 2.4 percent to $408.6 million.

This enhanced profitability, reflected in a gross margin increase from 12.2% to 13.4%, is attributed to the strategic pivot toward more predictable, recurring income. This high-margin revenue stream surged by an impressive 31.8 percent year-over-year, making the company’s financial performance less dependent on volatile project-based business.

Key annual financial metrics include:
* Annual Revenue: $3.04 billion (-6.7%)
* Adjusted EBITDA: $144.7 million (+2.8%)
* Non-GAAP EPS: $3.57 (+15.9%)
* Free Cash Flow: ~$104.1 million

Final Quarter Exceeds Projections

The company’s fourth-quarter performance notably surpassed market expectations. Net sales climbed 8.9 percent to reach $812.9 million, exceeding analyst forecasts. The specialty technology segment was a particular standout, registering 9.2 percent growth. This expansion was fueled by robust demand for mobility solutions, barcode technology, and physical security equipment.

Should investors sell immediately? Or is it worth buying ScanSource?

Profitability metrics were even more striking. Non-GAAP earnings per share (EPS) jumped to $1.02, a substantial increase from $0.80 reported in the same quarter last year. Even on a GAAP basis, EPS reached $0.88, representing a 37.5 percent gain.

Additional quarterly highlights were:
* Gross Profit: $105.1 million (+8.0%)
* Adjusted EBITDA: $38.6 million (+13.0%)

Confident Guidance for Fiscal 2026

Looking ahead, ScanSource’s leadership has issued an optimistic outlook for the new fiscal year. The company anticipates revenue to land between $3.1 billion and $3.3 billion. Adjusted EBITDA is projected to be in the range of $150 million to $160 million, with plans to generate a minimum of $80 million in free cash flow.

This forward guidance suggests the positive trend in profitability is expected to continue, even if overall revenue growth remains moderate. The company’s strategic focus on higher-margin, recurring business appears to be delivering tangible financial benefits.

Ad

ScanSource Stock: Buy or Sell?! New ScanSource Analysis from March 25 delivers the answer:

The latest ScanSource figures speak for themselves: Urgent action needed for ScanSource investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

ScanSource: Buy or sell? Read more here...

Tags: ScanSource
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Take-Two Stock
Earnings

GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon

March 25, 2026
IBM Stock
Analysis

IBM Shares Face Pressure from Analyst Downgrades and Acquisition Concerns

March 25, 2026
Battalion Oil Stock
Earnings

Battalion Oil Navigates Debt and Operational Overhaul

March 25, 2026
Next Post
Compass Therapeutics Stock

A Closer Look at Compass Therapeutics' Clinical and Financial Trajectory

Coinbase Stock

Coinbase's Strategic Pivot: Blending Tech Titans with Digital Assets

Alibaba Stock

Alibaba Shares Surge as Artificial Intelligence Investments Deliver Results

Recommended

BigBearai Holdings Stock

BigBear.ai Faces Critical Test as Revenue Plummets and Losses Mount

6 months ago
D-Wave Quantum Stock

D-Wave Quantum: CFO’s Multi-Million Dollar Exit Amidst Major Capital Raise

4 months ago
Brightcove Stock

Bending Spoons Forges AI-Powered Streaming Future with Brightcove at the Core

6 months ago
Microsoft Stock

Microsoft Faces Critical Earnings Test Amid AI Expectations

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

Realty Income’s Strategic Financing Defies High Interest Rate Environment

IBM Shares Face Pressure from Analyst Downgrades and Acquisition Concerns

Battalion Oil Navigates Debt and Operational Overhaul

Divergent Analyst Views Highlight Coeur Mining’s Strategic Transition

Rocket Lab Stock Attracts Bullish Analyst Sentiment Amid Growth Trajectory

Trending

Bionxt Solutions Stock
Healthcare

BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents

by SiterGedge
March 25, 2026
0

BioNxt Solutions has formally initiated the commercial phase for its sublingual drug delivery platform, marking a significant...

Take-Two Stock

GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon

March 25, 2026
Ocugen Stock

Ocugen Shares Slide Despite Positive Clinical Trial Results

March 25, 2026
ImmunityBio Stock

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

March 25, 2026
Realty Income Stock

Realty Income’s Strategic Financing Defies High Interest Rate Environment

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNxt Solutions Enters Pivotal Commercial Phase with Key Patents
  • GTA VI Launch Date Sets Stage for Take-Two’s Financial Horizon
  • Ocugen Shares Slide Despite Positive Clinical Trial Results

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com